Historique
Harm Reduction Journal, Vol.20. - 2023
| Titre : | Harm Reduction Journal, Vol.20. - 2023 |
| Type de document : | Bulletin |
| Paru le : | 01/01/2023 |
Dépouillements
Ajouter le résultat à votre sélection
M. TORRES-LEGUIZAMON ;
J. FAVARO ;
D. COELLO ;
E. G. REYNAUD ;
T. NÉFAU ;
C. DUPLESSY
|
2023
Dans Harm Reduction Journal (Vol.20, 2023) Article : Périodique
Dans Harm Reduction Journal (Vol.20, 2023) Article : Périodique
BACKGROUND: Harm Reduction (HR) policies for People Who Use Drugs (PWUD) have a significant positive impact on their health. Such approaches limit the spread of infections and reduce opioid overdose mortality. These policies have led to the open[...]
M. DI CIACCIO ;
V. VILLES ;
C. PERFECT ;
J. L. EL KAIM ;
M. DONATELLI ;
C. JAMES ;
P. EASTERBROOK ;
R. M. DELABRE
|
2023
Dans Harm Reduction Journal (Vol.20, 2023) Article : Périodique
Dans Harm Reduction Journal (Vol.20, 2023) Article : Périodique
BACKGROUND: To inform the development of updated World Health Organization (WHO) guidelines on simplified service delivery for HCV infection, a global survey was undertaken among people affected or infected by HCV. The objective of this analysis[...]
M. ISTVAN ;
V. BRESDIN ;
M. MAINGUY ;
P. LAIGO ;
M. GRALL-BRONNEC ;
V. EUDELINE ;
J. E. GUILLET ;
M. GUILLO ;
L. BABONNAUD ;
P. JOLLIET ;
B. SCHRECK ;
C. VICTORRI-VIGNEAU
|
2023
Dans Harm Reduction Journal (Vol.20, 2023) Article : Périodique
Dans Harm Reduction Journal (Vol.20, 2023) Article : Périodique
BACKGROUND: Illicit substance use has constantly evolved over the years, particularly in the party scene. Monitoring these changes is essential to adapt harm reduction strategies. The OCTOPUS survey was implemented to enhance knowledge on drug u[...]
T. AUSTIN ;
J. LAVALLEY ;
S. PARUSEL ;
A. B. COLLINS ;
M. OLDING ;
J. BOYD
|
2023
Dans Harm Reduction Journal (Vol.20, 2023) Article : Périodique
Dans Harm Reduction Journal (Vol.20, 2023) Article : Périodique
BACKGROUND: Harm reduction services that employ or are operated by people who use drugs are an effective means of mitigating overdose risks and other drug-related harms. However, stereotypes portraying people who use criminalized drugs as incapa[...]
H. DONNADIEU ;
C. QUILLET ;
M. D'OTTAVI ;
J. CASTELLANI ;
A. DEBELLEFONTAINE ;
S. GUICHARD ;
R. BAGLIONI ;
N. LANGENDORFER ;
V. FAUCHERRE ;
B. HANSLIK ;
E. TUAILLON ;
D. LAUREILLARD ;
N. NAGOT
|
2023
Dans Harm Reduction Journal (Vol.20, 2023) Article : Périodique
Dans Harm Reduction Journal (Vol.20, 2023) Article : Périodique
BACKGROUND: Understanding drug use and behavior within the PWUD population is crucial to adapt harm reduction and prevention strategies, and provide improved addiction and medical treatment. However, in most countries such as France, the knowled[...]
T. WILLEMAN ;
N. GRUNDIG ;
C. POCHON ;
D. MICHELS ;
N. CHARPENTIER ;
H. EYSSERIC-GUÉRIN ;
N. FOUILHE SAM-LAI ;
F. STANKE-LABESQUE ;
B. REVOL
|
2023
Dans Harm Reduction Journal (Vol.20, 2023) Article : Périodique
Dans Harm Reduction Journal (Vol.20, 2023) Article : Périodique
BACKGROUND: 3-methylmethcathinone (3-MMC) has been available on the European drug market for several years, but an increase in its availability seems to have occurred around 2020, associated with reports of harm and death. We aimed to analyze th[...]
A. ILHAME ;
C. DONADILLE ;
C. PROTOPOPESCU ;
D. MICHELS ;
J. HERIN ;
A. PLADYS ;
D. BADER ;
P. CARRIERI ;
P. ROUX
|
2023
Dans Harm Reduction Journal (Vol.20, 2023) Article : Périodique
Dans Harm Reduction Journal (Vol.20, 2023) Article : Périodique
BACKGROUND: Hepatitis C virus (HCV) infection prevalence is particularly high in people who inject drugs (PWID), a population that faces many barriers to HCV testing and care. A better understanding of the determinants of access to HCV testing i[...]
J. FREESTONE ;
N. EZARD ;
A. BOURNE ;
J. BRETT ;
D. M. ROBERTS ;
M. HAMMOUD ;
A. NEDANOSKI ;
G. PRESTAGE ;
K. J. SIEFRIED
|
2023
Dans Harm Reduction Journal (Vol.20, 2023) Article : Périodique
Dans Harm Reduction Journal (Vol.20, 2023) Article : Périodique
BACKGROUND: Gamma-hydroxybutyrate (GHB) is used at disproportionately high rates within sexuality and gender diverse communities and carries a high risk of overdose. GHB overdose can result in death. Internationally, recent increases in GHB over[...]
C. BERTIN ;
P. DECLE ;
P. CHAPPARD ;
P. ROUX ;
N. AUTHIER
|
2023
Dans Harm Reduction Journal (Vol.20, 2023) Article : Périodique
Dans Harm Reduction Journal (Vol.20, 2023) Article : Périodique
BACKGROUND: The French Addictovigilance network has observed the existence of the intravenous use of oral morphine capsules among people suffering from opioid use disorders. According to persons who inject morphine, these capsules are easy to di[...]
INTRODUCTION: Xylazine, an alpha2-adrenoceptor agonist sedative commonly used in veterinary medicine, is not approved for human use. Nevertheless, xylazine-involved overdose rates have surged in recent years, fueled by an increasingly toxic and [...]
M. CHAPPUY ;
P. LACK ;
B. DAVID ;
G. PENAVAYRE ;
D. THABOUREY ;
M. LANDULPHO ;
A. PLASSE ;
C. ICARD ;
F. BAILLY ;
F. BOUTAHRA ;
P. PRADAT ;
M. MAYNARD ;
M. JAUFFRET-ROUSTIDE ;
J. DE TERNAY ;
B. ROLLAND
|
2023
Dans Harm Reduction Journal (Vol.20, 2023) Article : Périodique
Dans Harm Reduction Journal (Vol.20, 2023) Article : Périodique
BACKGROUND: Drug consumption rooms (DCRs) have been developed in cities with open drug scenes, with the aim to reduce drug-related harm. In Lyon, France's second-largest city, there is no distinct drug use area, which raised doubts regarding the[...]